Cargando…

Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis

Salivary Aβ40, Aβ42, t-tau, and p-tau 181 are commonly employed in Alzheimer’s disease (AD) investigations. However, the collection method of these biomarkers can affect their levels. To assess the impact of saliva collection methods on biomarkers in this study, 15 healthy people were employed in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yangyang, Zhang, Hankun, Zhu, Jia, Liao, Zhenhua, Wang, Song, Liu, Weiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139762/
https://www.ncbi.nlm.nih.gov/pubmed/35624982
http://dx.doi.org/10.3390/brainsci12050595
_version_ 1784714934287859712
author Cui, Yangyang
Zhang, Hankun
Zhu, Jia
Liao, Zhenhua
Wang, Song
Liu, Weiqiang
author_facet Cui, Yangyang
Zhang, Hankun
Zhu, Jia
Liao, Zhenhua
Wang, Song
Liu, Weiqiang
author_sort Cui, Yangyang
collection PubMed
description Salivary Aβ40, Aβ42, t-tau, and p-tau 181 are commonly employed in Alzheimer’s disease (AD) investigations. However, the collection method of these biomarkers can affect their levels. To assess the impact of saliva collection methods on biomarkers in this study, 15 healthy people were employed in the morning with six saliva collection methods. The chosen methods were then applied in 30 AD patients and 30 non-AD controls. The levels of salivary biomarkers were calculated by a specific enzyme-linked immunosorbent assay. The receiver operating characteristic was utilized to assess salivary biomarkers in AD patients. The results demonstrated that the highest levels of salivary Aβ40, Aβ42, t-tau, and p-tau were in different saliva collection methods. The correlations between different saliva biomarkers in the same collection method were different. Salivary Aβ40, Aβ42, t-tau, and p-tau had no significant association. Salivary Aβ42 was higher in AD than in non-AD controls. However, p-tau/t-tau and Aβ42/Aβ40 had some relevance. The area under the curve for four biomarkers combined in AD diagnosis was 92.11%. An alternate saliva collection method (e.g., USS in Aβ40, UPS in Aβ42, t-tau, SSS in p-tau 181) was demonstrated in this study. Moreover, combining numerous biomarkers improves AD diagnosis.
format Online
Article
Text
id pubmed-9139762
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91397622022-05-28 Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis Cui, Yangyang Zhang, Hankun Zhu, Jia Liao, Zhenhua Wang, Song Liu, Weiqiang Brain Sci Article Salivary Aβ40, Aβ42, t-tau, and p-tau 181 are commonly employed in Alzheimer’s disease (AD) investigations. However, the collection method of these biomarkers can affect their levels. To assess the impact of saliva collection methods on biomarkers in this study, 15 healthy people were employed in the morning with six saliva collection methods. The chosen methods were then applied in 30 AD patients and 30 non-AD controls. The levels of salivary biomarkers were calculated by a specific enzyme-linked immunosorbent assay. The receiver operating characteristic was utilized to assess salivary biomarkers in AD patients. The results demonstrated that the highest levels of salivary Aβ40, Aβ42, t-tau, and p-tau were in different saliva collection methods. The correlations between different saliva biomarkers in the same collection method were different. Salivary Aβ40, Aβ42, t-tau, and p-tau had no significant association. Salivary Aβ42 was higher in AD than in non-AD controls. However, p-tau/t-tau and Aβ42/Aβ40 had some relevance. The area under the curve for four biomarkers combined in AD diagnosis was 92.11%. An alternate saliva collection method (e.g., USS in Aβ40, UPS in Aβ42, t-tau, SSS in p-tau 181) was demonstrated in this study. Moreover, combining numerous biomarkers improves AD diagnosis. MDPI 2022-05-03 /pmc/articles/PMC9139762/ /pubmed/35624982 http://dx.doi.org/10.3390/brainsci12050595 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cui, Yangyang
Zhang, Hankun
Zhu, Jia
Liao, Zhenhua
Wang, Song
Liu, Weiqiang
Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis
title Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis
title_full Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis
title_fullStr Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis
title_full_unstemmed Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis
title_short Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis
title_sort investigation of whole and glandular saliva as a biomarker for alzheimer’s disease diagnosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139762/
https://www.ncbi.nlm.nih.gov/pubmed/35624982
http://dx.doi.org/10.3390/brainsci12050595
work_keys_str_mv AT cuiyangyang investigationofwholeandglandularsalivaasabiomarkerforalzheimersdiseasediagnosis
AT zhanghankun investigationofwholeandglandularsalivaasabiomarkerforalzheimersdiseasediagnosis
AT zhujia investigationofwholeandglandularsalivaasabiomarkerforalzheimersdiseasediagnosis
AT liaozhenhua investigationofwholeandglandularsalivaasabiomarkerforalzheimersdiseasediagnosis
AT wangsong investigationofwholeandglandularsalivaasabiomarkerforalzheimersdiseasediagnosis
AT liuweiqiang investigationofwholeandglandularsalivaasabiomarkerforalzheimersdiseasediagnosis